ANI Announces Final US Approval And Launch Of Endari Generic
Marks The Firm’s Second US Launch This Month Alone
Executive Summary
Despite doubling down on its rare disease ambitions with its Alimera acquisition earlier in July, ANI just announced the second US launch of a generic this month.